Historically, BPDCN treatment relied on chemotherapy regimens adapted from leukemia or lymphoma protocols. However, recent breakthroughs have transformed the treatment paradigm. ELZONRIS (Stemline ...

BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component of the immune system that produces type 1 interferon cytokines. These cytokines ...

The unofficial results for the contested elections held Tuesday in the Naperville area, including city council, board board, school board and other races.

Learn more about the survey here. Help improve Ballotpedia - send us candidate contact info. Ballotpedia identified the following surveys, interviews, and questionnaires Blastic completed for other ...

Panelists discuss how optimizing shared-care models between academic and community centers enhances continuity in complex hematologic malignancies. Key monitoring parameters for tagraxofusp include ...

= candidate completed the Ballotpedia Candidate Connection survey. If you are a candidate and would like to tell readers and voters more about why they should vote for you, complete the Ballotpedia ...

Here's some information about each candidate for District 203 board member before you head to the polls Tuesday.

The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the detection of blastic plasmacytoid dendritic cell neoplasm (BPDCN).

The software provides a database of clinical images to help healthcare professionals diagnose skin conditions. Credit: Evgeniy Kalinovskiy/Shutterstock. The Menarini ...

VisualDx does not store any images uploaded by clinicians taking a picture of their patients' skin exams. This helps maintain the patient's privacy. About BPDCN BPDCN, formerly blastic NK-cell ...